[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Vistra Corp. (VST) reports a proposed sale of 19,596 common shares through Fidelity Brokerage Services with an aggregate market value of $3,905,511.14, to be sold on 09/30/2025 on the NYSE. The filing states the shares were acquired on 09/30/2025 via an option originally granted on 04/09/2018 and payment will be in cash. Recent transactions show the same beneficial owner, James A. Burke, executing multiple open-market sales in September 2025 on consecutive dates, with gross proceeds reported for each sale. The filer certifies no undisclosed material adverse information and references Rule 10b5-1 conditions if applicable.

Positive

• Filed as LIVE and includes full broker details (Fidelity Brokerage Services) and proposed sale date (09/30/2025)
• Discloses option grant date (04/09/2018) and acquisition date (09/30/2025), supporting compliance with Rule 144 timing requirements
• Includes prior sales history for transparency, listing multiple sale dates and gross proceeds

Negative

• No information on the seller’s ownership percentage or total beneficial holdings, limiting assessment of materiality
• Filing does not state whether sales are pursuant to a 10b5-1 plan (date of plan adoption not provided), leaving timing context unclear

Insights

Securities Analyst

TL;DR: Insider (or related person) plans a modest sale and has been selling shares repeatedly in September 2025.

The filing discloses a proposed single-sale block of 19,596 shares valued at $3.91M on 09/30/2025 and documents numerous prior sales by James A. Burke throughout September 2025 with multi-date gross proceeds. This pattern indicates active disposition by the account holder rather than a one-off trade. The shares to be sold were acquired under an option granted in 2018 and appear to be exercised or delivered on 09/30/2025 with cash payment. There is no additional financial performance data, no forward-looking statement, and no disclosure of ownership percentage or insider relationship beyond the name provided. Impact to investors is neutral absent broader context on ownership stake or company fundamentals.

Corporate Governance Expert

TL;DR: Routine Rule 144 disclosure showing compliance; multiple prior sales suggest systematic liquidation or planned trading.

The Form 144 provides required notice for sale under Rule 144 and includes a representation that no material nonpublic information is known. The record of consecutive daily sales by the same named seller suggests either an executed trading plan or systematic liquidation. The filing notes an option grant date of 04/09/2018 as the origin of the shares to be sold. There is no indication in the filing of any governance action, change in control, or regulatory issue. From a governance perspective, the disclosure meets procedural requirements; materiality depends on the seller's overall stake, which is not disclosed here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	19596	3905511.14	338820324	09/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2025	Option Granted - 04/09/2018	Issuer			19596	09/30/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/15/2025	21362	4481773.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/16/2025	21358	4565882.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/17/2025	21361	4540506.03
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/18/2025	21366	4554708.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/19/2025	21360	4517570.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/22/2025	21362	4503715.06
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/23/2025	21360	4490151.57
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/24/2025	21371	4355909.13
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/25/2025	21376	4273632.11
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/26/2025	21376	4300490.42
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/29/2025	21378	4316995.04

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Vistra Corp. (VST) report?

The Form 144 reports a proposed sale of 19,596 common shares valued at $3,905,511.14 to be sold on 09/30/2025 on the NYSE via Fidelity Brokerage Services.

Who executed recent sales reported in the filing?

The filing lists James A. Burke as the seller for multiple open-market common stock sales on various dates in September 2025, with gross proceeds shown for each sale.

How were the shares being sold acquired?

The shares to be sold were acquired on 09/30/2025 and originate from an option granted on 04/09/2018; payment for the current proposed sale is noted as cash.

Does the filing state whether a Rule 10b5-1 plan applies?

The filing includes the Rule 10b5-1 representation language but does not provide a plan adoption date or explicit confirmation that a 10b5-1 plan governs the sales.

What exchange will the sale occur on?

The proposed sale is listed for the NYSE.